Zentalis Pharmaceuticals Inc (ZNTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 54,951 | 67,246 | N/A | N/A |
| Marketable Securities | 283,554 | N/A | N/A | N/A |
| Receivables | 417 | 140 | N/A | N/A |
| TOTAL | $345,104 | $68,891 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 1,099 | 501 | N/A | N/A |
| Intangibles | 12,536 | 12,536 | 0 | 0 |
| Other Non-Current Assets | 6,816 | 5,553 | 0 | 0 |
| TOTAL | $20,451 | $18,590 | $N/A | $N/A |
| Total Assets | $365,555 | $87,481 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 8,661 | 4,289 | 0 | 0 |
| Accrued Expenses | 19,940 | 10,608 | N/A | N/A |
| TOTAL | $28,601 | $14,897 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 1,804 | 144,121 | 0 | 0 |
| TOTAL | $3,577 | $145,869 | $N/A | $N/A |
| Total Liabilities | $32,178 | $160,766 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 41,040 | N/A | N/A | N/A |
| Common Shares | 41 | 2,887 | N/A | N/A |
| Retained earnings | -200,834 | -82,993 | N/A | N/A |
| Other shareholders' equity | 24,831 | 6,821 | 0 | 0 |
| TOTAL | $333,377 | $-73,285 | $N/A | $N/A |
| Total Liabilities And Equity | $365,555 | $87,481 | $0 | $0 |